Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05607043 · ClinicalTrials.gov registry record · NA

Rutgers Pilot for PREDICT- Patient LAB Test

A NA study, sponsored by Rutgers, The State University of New Jersey.

Completed
Registry status
NA
Development phase
11
Enrollment target

NCT05607043 is a NA study that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 11 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05607043, a NA study, has completed, sponsored by Rutgers, The State University of New Jersey.

COMPLETED
Registry status
NA
Development phase
11 participants
Enrollment target

Study Summary

A pilot study was initiated to assess feasibility of testing asymptomatic dental patients presenting to the Oral Medicine Clinic at Rutgers School of Dental Medicine for SARS-CoV-2 viral RNA using an FDA approved RT-PCR test for SARS-CoV2- an RNA RT-PCR assay (Accurate Diagnostics)

Interventions

  • DEVICE Testing for SARS CoV2 RNA

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2021-01-31
Est. Completion 2021-02-25
Phase NA

What the Registry Record Tells You About NCT05607043

The ClinicalTrials.gov registry entry for NCT05607043 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Testing for SARS CoV2 RNA is the first listed.

NCT05607043 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05607043 about?

NCT05607043 is a clinical study titled "Rutgers Pilot for PREDICT- Patient LAB Test". A pilot study was initiated to assess feasibility of testing asymptomatic dental patients presenting to the Oral Medicine Clinic at Rutgers School of Dental Medicine for SARS-CoV-2 viral RNA using an FDA approved RT-PCR test for SARS-CoV2- an RNA RT-PCR assay (Accurate Diagnostics)

What is the current status of trial NCT05607043?

This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2021-01-31. Estimated completion is 2021-02-25.

What interventions are being tested in trial NCT05607043?

The interventions under investigation include: Testing for SARS CoV2 RNA (DEVICE).

Who is sponsoring clinical trial NCT05607043?

This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.